Photodisinfection for Refractory Chronic Rhinosinusitis Patients: A much needed advance for an under-served patient population

Chronic rhinosinusitis (CRS) is one of the most common chronic conditions in the United States. There is a significant subpopulation of CRS patients who remain resistant to cure despite rigorous treatment regimens including surgery, allergy therapy, and prolonged antibiotic therapy. This refractory patient population is thought to exceed 500,000 in the US.

Photodisinfection, also known as antimicrobial photodynamic therapy (aPDT), is a noninvasive, non-antibiotic broad spectrum antimicrobial treatment that can improve outcomes for this under-served patient population by reducing inflammation of sinus tissue and eliminating biofilm in the sinuses. Patients  suffering from refractory Chronic Rhinosinusitis are likely to be infected by super-antigen producing bacterial such as Staph aureus and Pseudomonas aeruginosa. Photodisinfection has been proven to be highly effective at targeting these two pathogens and inactivating inflammatory cytokines.

Related Posts Plugin for WordPress, Blogger...

One Response to “Photodisinfection for Refractory Chronic Rhinosinusitis Patients: A much needed advance for an under-served patient population”

  1. Nancy Abrams says:

    Would love more information. The Sinuwave site states not found, so cannot access photodisinfection for sinusitis.
    Thank You
    Nancy Abrams, RN, B-C

Leave a Reply

Staypressed theme by Themocracy